Namely, METTL3 actuates CRC cell stemness in vitro by maintaining SOX2 expression and inhibition of METTL3 was associated with markedly decreased CSC surface antigens such as CD133, CD44, and epithelial cell adhesion molecule (EpCAM) (19). This evidence concerns the gene METTL3 and colorectal carcinoma.